Global Antimalarial Medication Market Growth 2025-2031
The global Antimalarial Medication market size is predicted to grow from US$ 1488 million in 2025 to US$ 1942 million in 2031; it is expected to grow at a CAGR of 4.5% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Malaria is a life-threatening disease caused by parasites which are transmitted to people through the bite of an infected female anopheles mosquitoes. This disease is preventable and curable. Humans are infected by four recognized species of malarial parasites, namely, Plasmodium falciparum, P. vivax, P. ovale, and P. malariae.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Antimalarial Medication Industry Forecast? looks at past sales and reviews total world Antimalarial Medication sales in 2024, providing a comprehensive analysis by region and market sector of projected Antimalarial Medication sales for 2025 through 2031. With Antimalarial Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antimalarial Medication industry.
This Insight Report provides a comprehensive analysis of the global Antimalarial Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antimalarial Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Antimalarial Medication market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antimalarial Medication and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antimalarial Medication.
This report presents a comprehensive overview, market shares, and growth opportunities of Antimalarial Medication market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Antimalarial Medication market?
What factors are driving Antimalarial Medication market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antimalarial Medication market opportunities vary by end market size?
How does Antimalarial Medication break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Malaria is a life-threatening disease caused by parasites which are transmitted to people through the bite of an infected female anopheles mosquitoes. This disease is preventable and curable. Humans are infected by four recognized species of malarial parasites, namely, Plasmodium falciparum, P. vivax, P. ovale, and P. malariae.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Antimalarial Medication Industry Forecast? looks at past sales and reviews total world Antimalarial Medication sales in 2024, providing a comprehensive analysis by region and market sector of projected Antimalarial Medication sales for 2025 through 2031. With Antimalarial Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antimalarial Medication industry.
This Insight Report provides a comprehensive analysis of the global Antimalarial Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antimalarial Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Antimalarial Medication market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antimalarial Medication and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antimalarial Medication.
This report presents a comprehensive overview, market shares, and growth opportunities of Antimalarial Medication market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Plasmodium Falciparum
- Plasmodium Malariae
- Plasmodium Vivax
- Plasmodium Ovale
- Hospital Pharmacy
- Retail Pharmacy
- E- Commerce
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GlaxoSmithKline
- F. Hoffmann-La Roche
- Novartis
- Pfizer
- Sun Pharmaceutical Industries
- Merck
What is the 10-year outlook for the global Antimalarial Medication market?
What factors are driving Antimalarial Medication market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antimalarial Medication market opportunities vary by end market size?
How does Antimalarial Medication break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antimalarial Medication Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Antimalarial Medication by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Antimalarial Medication by Country/Region, 2020, 2024 & 2031
2.2 Antimalarial Medication Segment by Type
2.2.1 Plasmodium Falciparum
2.2.2 Plasmodium Malariae
2.2.3 Plasmodium Vivax
2.2.4 Plasmodium Ovale
2.3 Antimalarial Medication Sales by Type
2.3.1 Global Antimalarial Medication Sales Market Share by Type (2020-2025)
2.3.2 Global Antimalarial Medication Revenue and Market Share by Type (2020-2025)
2.3.3 Global Antimalarial Medication Sale Price by Type (2020-2025)
2.4 Antimalarial Medication Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 E- Commerce
2.4.4 Others
2.5 Antimalarial Medication Sales by Application
2.5.1 Global Antimalarial Medication Sale Market Share by Application (2020-2025)
2.5.2 Global Antimalarial Medication Revenue and Market Share by Application (2020-2025)
2.5.3 Global Antimalarial Medication Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Antimalarial Medication Breakdown Data by Company
3.1.1 Global Antimalarial Medication Annual Sales by Company (2020-2025)
3.1.2 Global Antimalarial Medication Sales Market Share by Company (2020-2025)
3.2 Global Antimalarial Medication Annual Revenue by Company (2020-2025)
3.2.1 Global Antimalarial Medication Revenue by Company (2020-2025)
3.2.2 Global Antimalarial Medication Revenue Market Share by Company (2020-2025)
3.3 Global Antimalarial Medication Sale Price by Company
3.4 Key Manufacturers Antimalarial Medication Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antimalarial Medication Product Location Distribution
3.4.2 Players Antimalarial Medication Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTIMALARIAL MEDICATION BY GEOGRAPHIC REGION
4.1 World Historic Antimalarial Medication Market Size by Geographic Region (2020-2025)
4.1.1 Global Antimalarial Medication Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Antimalarial Medication Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Antimalarial Medication Market Size by Country/Region (2020-2025)
4.2.1 Global Antimalarial Medication Annual Sales by Country/Region (2020-2025)
4.2.2 Global Antimalarial Medication Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antimalarial Medication Sales Growth
4.4 APAC Antimalarial Medication Sales Growth
4.5 Europe Antimalarial Medication Sales Growth
4.6 Middle East & Africa Antimalarial Medication Sales Growth
5 AMERICAS
5.1 Americas Antimalarial Medication Sales by Country
5.1.1 Americas Antimalarial Medication Sales by Country (2020-2025)
5.1.2 Americas Antimalarial Medication Revenue by Country (2020-2025)
5.2 Americas Antimalarial Medication Sales by Type (2020-2025)
5.3 Americas Antimalarial Medication Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antimalarial Medication Sales by Region
6.1.1 APAC Antimalarial Medication Sales by Region (2020-2025)
6.1.2 APAC Antimalarial Medication Revenue by Region (2020-2025)
6.2 APAC Antimalarial Medication Sales by Type (2020-2025)
6.3 APAC Antimalarial Medication Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antimalarial Medication by Country
7.1.1 Europe Antimalarial Medication Sales by Country (2020-2025)
7.1.2 Europe Antimalarial Medication Revenue by Country (2020-2025)
7.2 Europe Antimalarial Medication Sales by Type (2020-2025)
7.3 Europe Antimalarial Medication Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antimalarial Medication by Country
8.1.1 Middle East & Africa Antimalarial Medication Sales by Country (2020-2025)
8.1.2 Middle East & Africa Antimalarial Medication Revenue by Country (2020-2025)
8.2 Middle East & Africa Antimalarial Medication Sales by Type (2020-2025)
8.3 Middle East & Africa Antimalarial Medication Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antimalarial Medication
10.3 Manufacturing Process Analysis of Antimalarial Medication
10.4 Industry Chain Structure of Antimalarial Medication
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antimalarial Medication Distributors
11.3 Antimalarial Medication Customer
12 WORLD FORECAST REVIEW FOR ANTIMALARIAL MEDICATION BY GEOGRAPHIC REGION
12.1 Global Antimalarial Medication Market Size Forecast by Region
12.1.1 Global Antimalarial Medication Forecast by Region (2026-2031)
12.1.2 Global Antimalarial Medication Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Antimalarial Medication Forecast by Type (2026-2031)
12.7 Global Antimalarial Medication Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Antimalarial Medication Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Antimalarial Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 F. Hoffmann-La Roche
13.2.1 F. Hoffmann-La Roche Company Information
13.2.2 F. Hoffmann-La Roche Antimalarial Medication Product Portfolios and Specifications
13.2.3 F. Hoffmann-La Roche Antimalarial Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 F. Hoffmann-La Roche Main Business Overview
13.2.5 F. Hoffmann-La Roche Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Antimalarial Medication Product Portfolios and Specifications
13.3.3 Novartis Antimalarial Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Antimalarial Medication Product Portfolios and Specifications
13.4.3 Pfizer Antimalarial Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Sun Pharmaceutical Industries
13.5.1 Sun Pharmaceutical Industries Company Information
13.5.2 Sun Pharmaceutical Industries Antimalarial Medication Product Portfolios and Specifications
13.5.3 Sun Pharmaceutical Industries Antimalarial Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Sun Pharmaceutical Industries Main Business Overview
13.5.5 Sun Pharmaceutical Industries Latest Developments
13.6 Merck
13.6.1 Merck Company Information
13.6.2 Merck Antimalarial Medication Product Portfolios and Specifications
13.6.3 Merck Antimalarial Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Merck Main Business Overview
13.6.5 Merck Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antimalarial Medication Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Antimalarial Medication by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Antimalarial Medication by Country/Region, 2020, 2024 & 2031
2.2 Antimalarial Medication Segment by Type
2.2.1 Plasmodium Falciparum
2.2.2 Plasmodium Malariae
2.2.3 Plasmodium Vivax
2.2.4 Plasmodium Ovale
2.3 Antimalarial Medication Sales by Type
2.3.1 Global Antimalarial Medication Sales Market Share by Type (2020-2025)
2.3.2 Global Antimalarial Medication Revenue and Market Share by Type (2020-2025)
2.3.3 Global Antimalarial Medication Sale Price by Type (2020-2025)
2.4 Antimalarial Medication Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 E- Commerce
2.4.4 Others
2.5 Antimalarial Medication Sales by Application
2.5.1 Global Antimalarial Medication Sale Market Share by Application (2020-2025)
2.5.2 Global Antimalarial Medication Revenue and Market Share by Application (2020-2025)
2.5.3 Global Antimalarial Medication Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Antimalarial Medication Breakdown Data by Company
3.1.1 Global Antimalarial Medication Annual Sales by Company (2020-2025)
3.1.2 Global Antimalarial Medication Sales Market Share by Company (2020-2025)
3.2 Global Antimalarial Medication Annual Revenue by Company (2020-2025)
3.2.1 Global Antimalarial Medication Revenue by Company (2020-2025)
3.2.2 Global Antimalarial Medication Revenue Market Share by Company (2020-2025)
3.3 Global Antimalarial Medication Sale Price by Company
3.4 Key Manufacturers Antimalarial Medication Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antimalarial Medication Product Location Distribution
3.4.2 Players Antimalarial Medication Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTIMALARIAL MEDICATION BY GEOGRAPHIC REGION
4.1 World Historic Antimalarial Medication Market Size by Geographic Region (2020-2025)
4.1.1 Global Antimalarial Medication Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Antimalarial Medication Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Antimalarial Medication Market Size by Country/Region (2020-2025)
4.2.1 Global Antimalarial Medication Annual Sales by Country/Region (2020-2025)
4.2.2 Global Antimalarial Medication Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antimalarial Medication Sales Growth
4.4 APAC Antimalarial Medication Sales Growth
4.5 Europe Antimalarial Medication Sales Growth
4.6 Middle East & Africa Antimalarial Medication Sales Growth
5 AMERICAS
5.1 Americas Antimalarial Medication Sales by Country
5.1.1 Americas Antimalarial Medication Sales by Country (2020-2025)
5.1.2 Americas Antimalarial Medication Revenue by Country (2020-2025)
5.2 Americas Antimalarial Medication Sales by Type (2020-2025)
5.3 Americas Antimalarial Medication Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antimalarial Medication Sales by Region
6.1.1 APAC Antimalarial Medication Sales by Region (2020-2025)
6.1.2 APAC Antimalarial Medication Revenue by Region (2020-2025)
6.2 APAC Antimalarial Medication Sales by Type (2020-2025)
6.3 APAC Antimalarial Medication Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antimalarial Medication by Country
7.1.1 Europe Antimalarial Medication Sales by Country (2020-2025)
7.1.2 Europe Antimalarial Medication Revenue by Country (2020-2025)
7.2 Europe Antimalarial Medication Sales by Type (2020-2025)
7.3 Europe Antimalarial Medication Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antimalarial Medication by Country
8.1.1 Middle East & Africa Antimalarial Medication Sales by Country (2020-2025)
8.1.2 Middle East & Africa Antimalarial Medication Revenue by Country (2020-2025)
8.2 Middle East & Africa Antimalarial Medication Sales by Type (2020-2025)
8.3 Middle East & Africa Antimalarial Medication Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antimalarial Medication
10.3 Manufacturing Process Analysis of Antimalarial Medication
10.4 Industry Chain Structure of Antimalarial Medication
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antimalarial Medication Distributors
11.3 Antimalarial Medication Customer
12 WORLD FORECAST REVIEW FOR ANTIMALARIAL MEDICATION BY GEOGRAPHIC REGION
12.1 Global Antimalarial Medication Market Size Forecast by Region
12.1.1 Global Antimalarial Medication Forecast by Region (2026-2031)
12.1.2 Global Antimalarial Medication Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Antimalarial Medication Forecast by Type (2026-2031)
12.7 Global Antimalarial Medication Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Antimalarial Medication Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Antimalarial Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 F. Hoffmann-La Roche
13.2.1 F. Hoffmann-La Roche Company Information
13.2.2 F. Hoffmann-La Roche Antimalarial Medication Product Portfolios and Specifications
13.2.3 F. Hoffmann-La Roche Antimalarial Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 F. Hoffmann-La Roche Main Business Overview
13.2.5 F. Hoffmann-La Roche Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Antimalarial Medication Product Portfolios and Specifications
13.3.3 Novartis Antimalarial Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Antimalarial Medication Product Portfolios and Specifications
13.4.3 Pfizer Antimalarial Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Sun Pharmaceutical Industries
13.5.1 Sun Pharmaceutical Industries Company Information
13.5.2 Sun Pharmaceutical Industries Antimalarial Medication Product Portfolios and Specifications
13.5.3 Sun Pharmaceutical Industries Antimalarial Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Sun Pharmaceutical Industries Main Business Overview
13.5.5 Sun Pharmaceutical Industries Latest Developments
13.6 Merck
13.6.1 Merck Company Information
13.6.2 Merck Antimalarial Medication Product Portfolios and Specifications
13.6.3 Merck Antimalarial Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Merck Main Business Overview
13.6.5 Merck Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Antimalarial Medication Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Antimalarial Medication Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Plasmodium Falciparum
Table 4. Major Players of Plasmodium Malariae
Table 5. Major Players of Plasmodium Vivax
Table 6. Major Players of Plasmodium Ovale
Table 7. Global Antimalarial Medication Sales by Type (2020-2025) & (K Units)
Table 8. Global Antimalarial Medication Sales Market Share by Type (2020-2025)
Table 9. Global Antimalarial Medication Revenue by Type (2020-2025) & ($ million)
Table 10. Global Antimalarial Medication Revenue Market Share by Type (2020-2025)
Table 11. Global Antimalarial Medication Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Antimalarial Medication Sale by Application (2020-2025) & (K Units)
Table 13. Global Antimalarial Medication Sale Market Share by Application (2020-2025)
Table 14. Global Antimalarial Medication Revenue by Application (2020-2025) & ($ million)
Table 15. Global Antimalarial Medication Revenue Market Share by Application (2020-2025)
Table 16. Global Antimalarial Medication Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Antimalarial Medication Sales by Company (2020-2025) & (K Units)
Table 18. Global Antimalarial Medication Sales Market Share by Company (2020-2025)
Table 19. Global Antimalarial Medication Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Antimalarial Medication Revenue Market Share by Company (2020-2025)
Table 21. Global Antimalarial Medication Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Antimalarial Medication Producing Area Distribution and Sales Area
Table 23. Players Antimalarial Medication Products Offered
Table 24. Antimalarial Medication Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Antimalarial Medication Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Antimalarial Medication Sales Market Share Geographic Region (2020-2025)
Table 29. Global Antimalarial Medication Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Antimalarial Medication Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Antimalarial Medication Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Antimalarial Medication Sales Market Share by Country/Region (2020-2025)
Table 33. Global Antimalarial Medication Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Antimalarial Medication Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Antimalarial Medication Sales by Country (2020-2025) & (K Units)
Table 36. Americas Antimalarial Medication Sales Market Share by Country (2020-2025)
Table 37. Americas Antimalarial Medication Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Antimalarial Medication Sales by Type (2020-2025) & (K Units)
Table 39. Americas Antimalarial Medication Sales by Application (2020-2025) & (K Units)
Table 40. APAC Antimalarial Medication Sales by Region (2020-2025) & (K Units)
Table 41. APAC Antimalarial Medication Sales Market Share by Region (2020-2025)
Table 42. APAC Antimalarial Medication Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Antimalarial Medication Sales by Type (2020-2025) & (K Units)
Table 44. APAC Antimalarial Medication Sales by Application (2020-2025) & (K Units)
Table 45. Europe Antimalarial Medication Sales by Country (2020-2025) & (K Units)
Table 46. Europe Antimalarial Medication Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Antimalarial Medication Sales by Type (2020-2025) & (K Units)
Table 48. Europe Antimalarial Medication Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Antimalarial Medication Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Antimalarial Medication Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Antimalarial Medication Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Antimalarial Medication Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Antimalarial Medication
Table 54. Key Market Challenges & Risks of Antimalarial Medication
Table 55. Key Industry Trends of Antimalarial Medication
Table 56. Antimalarial Medication Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Antimalarial Medication Distributors List
Table 59. Antimalarial Medication Customer List
Table 60. Global Antimalarial Medication Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Antimalarial Medication Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Antimalarial Medication Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Antimalarial Medication Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Antimalarial Medication Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Antimalarial Medication Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Antimalarial Medication Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Antimalarial Medication Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Antimalarial Medication Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Antimalarial Medication Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Antimalarial Medication Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Antimalarial Medication Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Antimalarial Medication Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Antimalarial Medication Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. GlaxoSmithKline Basic Information, Antimalarial Medication Manufacturing Base, Sales Area and Its Competitors
Table 75. GlaxoSmithKline Antimalarial Medication Product Portfolios and Specifications
Table 76. GlaxoSmithKline Antimalarial Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. GlaxoSmithKline Main Business
Table 78. GlaxoSmithKline Latest Developments
Table 79. F. Hoffmann-La Roche Basic Information, Antimalarial Medication Manufacturing Base, Sales Area and Its Competitors
Table 80. F. Hoffmann-La Roche Antimalarial Medication Product Portfolios and Specifications
Table 81. F. Hoffmann-La Roche Antimalarial Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. F. Hoffmann-La Roche Main Business
Table 83. F. Hoffmann-La Roche Latest Developments
Table 84. Novartis Basic Information, Antimalarial Medication Manufacturing Base, Sales Area and Its Competitors
Table 85. Novartis Antimalarial Medication Product Portfolios and Specifications
Table 86. Novartis Antimalarial Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Novartis Main Business
Table 88. Novartis Latest Developments
Table 89. Pfizer Basic Information, Antimalarial Medication Manufacturing Base, Sales Area and Its Competitors
Table 90. Pfizer Antimalarial Medication Product Portfolios and Specifications
Table 91. Pfizer Antimalarial Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Pfizer Main Business
Table 93. Pfizer Latest Developments
Table 94. Sun Pharmaceutical Industries Basic Information, Antimalarial Medication Manufacturing Base, Sales Area and Its Competitors
Table 95. Sun Pharmaceutical Industries Antimalarial Medication Product Portfolios and Specifications
Table 96. Sun Pharmaceutical Industries Antimalarial Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Sun Pharmaceutical Industries Main Business
Table 98. Sun Pharmaceutical Industries Latest Developments
Table 99. Merck Basic Information, Antimalarial Medication Manufacturing Base, Sales Area and Its Competitors
Table 100. Merck Antimalarial Medication Product Portfolios and Specifications
Table 101. Merck Antimalarial Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Merck Main Business
Table 103. Merck Latest Developments
Table 1. Antimalarial Medication Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Antimalarial Medication Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Plasmodium Falciparum
Table 4. Major Players of Plasmodium Malariae
Table 5. Major Players of Plasmodium Vivax
Table 6. Major Players of Plasmodium Ovale
Table 7. Global Antimalarial Medication Sales by Type (2020-2025) & (K Units)
Table 8. Global Antimalarial Medication Sales Market Share by Type (2020-2025)
Table 9. Global Antimalarial Medication Revenue by Type (2020-2025) & ($ million)
Table 10. Global Antimalarial Medication Revenue Market Share by Type (2020-2025)
Table 11. Global Antimalarial Medication Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Antimalarial Medication Sale by Application (2020-2025) & (K Units)
Table 13. Global Antimalarial Medication Sale Market Share by Application (2020-2025)
Table 14. Global Antimalarial Medication Revenue by Application (2020-2025) & ($ million)
Table 15. Global Antimalarial Medication Revenue Market Share by Application (2020-2025)
Table 16. Global Antimalarial Medication Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Antimalarial Medication Sales by Company (2020-2025) & (K Units)
Table 18. Global Antimalarial Medication Sales Market Share by Company (2020-2025)
Table 19. Global Antimalarial Medication Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Antimalarial Medication Revenue Market Share by Company (2020-2025)
Table 21. Global Antimalarial Medication Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Antimalarial Medication Producing Area Distribution and Sales Area
Table 23. Players Antimalarial Medication Products Offered
Table 24. Antimalarial Medication Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Antimalarial Medication Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Antimalarial Medication Sales Market Share Geographic Region (2020-2025)
Table 29. Global Antimalarial Medication Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Antimalarial Medication Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Antimalarial Medication Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Antimalarial Medication Sales Market Share by Country/Region (2020-2025)
Table 33. Global Antimalarial Medication Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Antimalarial Medication Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Antimalarial Medication Sales by Country (2020-2025) & (K Units)
Table 36. Americas Antimalarial Medication Sales Market Share by Country (2020-2025)
Table 37. Americas Antimalarial Medication Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Antimalarial Medication Sales by Type (2020-2025) & (K Units)
Table 39. Americas Antimalarial Medication Sales by Application (2020-2025) & (K Units)
Table 40. APAC Antimalarial Medication Sales by Region (2020-2025) & (K Units)
Table 41. APAC Antimalarial Medication Sales Market Share by Region (2020-2025)
Table 42. APAC Antimalarial Medication Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Antimalarial Medication Sales by Type (2020-2025) & (K Units)
Table 44. APAC Antimalarial Medication Sales by Application (2020-2025) & (K Units)
Table 45. Europe Antimalarial Medication Sales by Country (2020-2025) & (K Units)
Table 46. Europe Antimalarial Medication Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Antimalarial Medication Sales by Type (2020-2025) & (K Units)
Table 48. Europe Antimalarial Medication Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Antimalarial Medication Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Antimalarial Medication Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Antimalarial Medication Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Antimalarial Medication Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Antimalarial Medication
Table 54. Key Market Challenges & Risks of Antimalarial Medication
Table 55. Key Industry Trends of Antimalarial Medication
Table 56. Antimalarial Medication Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Antimalarial Medication Distributors List
Table 59. Antimalarial Medication Customer List
Table 60. Global Antimalarial Medication Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Antimalarial Medication Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Antimalarial Medication Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Antimalarial Medication Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Antimalarial Medication Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Antimalarial Medication Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Antimalarial Medication Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Antimalarial Medication Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Antimalarial Medication Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Antimalarial Medication Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Antimalarial Medication Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Antimalarial Medication Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Antimalarial Medication Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Antimalarial Medication Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. GlaxoSmithKline Basic Information, Antimalarial Medication Manufacturing Base, Sales Area and Its Competitors
Table 75. GlaxoSmithKline Antimalarial Medication Product Portfolios and Specifications
Table 76. GlaxoSmithKline Antimalarial Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. GlaxoSmithKline Main Business
Table 78. GlaxoSmithKline Latest Developments
Table 79. F. Hoffmann-La Roche Basic Information, Antimalarial Medication Manufacturing Base, Sales Area and Its Competitors
Table 80. F. Hoffmann-La Roche Antimalarial Medication Product Portfolios and Specifications
Table 81. F. Hoffmann-La Roche Antimalarial Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. F. Hoffmann-La Roche Main Business
Table 83. F. Hoffmann-La Roche Latest Developments
Table 84. Novartis Basic Information, Antimalarial Medication Manufacturing Base, Sales Area and Its Competitors
Table 85. Novartis Antimalarial Medication Product Portfolios and Specifications
Table 86. Novartis Antimalarial Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Novartis Main Business
Table 88. Novartis Latest Developments
Table 89. Pfizer Basic Information, Antimalarial Medication Manufacturing Base, Sales Area and Its Competitors
Table 90. Pfizer Antimalarial Medication Product Portfolios and Specifications
Table 91. Pfizer Antimalarial Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Pfizer Main Business
Table 93. Pfizer Latest Developments
Table 94. Sun Pharmaceutical Industries Basic Information, Antimalarial Medication Manufacturing Base, Sales Area and Its Competitors
Table 95. Sun Pharmaceutical Industries Antimalarial Medication Product Portfolios and Specifications
Table 96. Sun Pharmaceutical Industries Antimalarial Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Sun Pharmaceutical Industries Main Business
Table 98. Sun Pharmaceutical Industries Latest Developments
Table 99. Merck Basic Information, Antimalarial Medication Manufacturing Base, Sales Area and Its Competitors
Table 100. Merck Antimalarial Medication Product Portfolios and Specifications
Table 101. Merck Antimalarial Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Merck Main Business
Table 103. Merck Latest Developments
LIST OF FIGURES
Figure 1. Picture of Antimalarial Medication
Figure 2. Antimalarial Medication Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antimalarial Medication Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Antimalarial Medication Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Antimalarial Medication Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Antimalarial Medication Sales Market Share by Country/Region (2024)
Figure 10. Antimalarial Medication Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Plasmodium Falciparum
Figure 12. Product Picture of Plasmodium Malariae
Figure 13. Product Picture of Plasmodium Vivax
Figure 14. Product Picture of Plasmodium Ovale
Figure 15. Global Antimalarial Medication Sales Market Share by Type in 2025
Figure 16. Global Antimalarial Medication Revenue Market Share by Type (2020-2025)
Figure 17. Antimalarial Medication Consumed in Hospital Pharmacy
Figure 18. Global Antimalarial Medication Market: Hospital Pharmacy (2020-2025) & (K Units)
Figure 19. Antimalarial Medication Consumed in Retail Pharmacy
Figure 20. Global Antimalarial Medication Market: Retail Pharmacy (2020-2025) & (K Units)
Figure 21. Antimalarial Medication Consumed in E- Commerce
Figure 22. Global Antimalarial Medication Market: E- Commerce (2020-2025) & (K Units)
Figure 23. Antimalarial Medication Consumed in Others
Figure 24. Global Antimalarial Medication Market: Others (2020-2025) & (K Units)
Figure 25. Global Antimalarial Medication Sale Market Share by Application (2024)
Figure 26. Global Antimalarial Medication Revenue Market Share by Application in 2025
Figure 27. Antimalarial Medication Sales by Company in 2025 (K Units)
Figure 28. Global Antimalarial Medication Sales Market Share by Company in 2025
Figure 29. Antimalarial Medication Revenue by Company in 2025 ($ millions)
Figure 30. Global Antimalarial Medication Revenue Market Share by Company in 2025
Figure 31. Global Antimalarial Medication Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Antimalarial Medication Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Antimalarial Medication Sales 2020-2025 (K Units)
Figure 34. Americas Antimalarial Medication Revenue 2020-2025 ($ millions)
Figure 35. APAC Antimalarial Medication Sales 2020-2025 (K Units)
Figure 36. APAC Antimalarial Medication Revenue 2020-2025 ($ millions)
Figure 37. Europe Antimalarial Medication Sales 2020-2025 (K Units)
Figure 38. Europe Antimalarial Medication Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Antimalarial Medication Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Antimalarial Medication Revenue 2020-2025 ($ millions)
Figure 41. Americas Antimalarial Medication Sales Market Share by Country in 2025
Figure 42. Americas Antimalarial Medication Revenue Market Share by Country (2020-2025)
Figure 43. Americas Antimalarial Medication Sales Market Share by Type (2020-2025)
Figure 44. Americas Antimalarial Medication Sales Market Share by Application (2020-2025)
Figure 45. United States Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Antimalarial Medication Sales Market Share by Region in 2025
Figure 50. APAC Antimalarial Medication Revenue Market Share by Region (2020-2025)
Figure 51. APAC Antimalarial Medication Sales Market Share by Type (2020-2025)
Figure 52. APAC Antimalarial Medication Sales Market Share by Application (2020-2025)
Figure 53. China Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 57. India Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Antimalarial Medication Sales Market Share by Country in 2025
Figure 61. Europe Antimalarial Medication Revenue Market Share by Country (2020-2025)
Figure 62. Europe Antimalarial Medication Sales Market Share by Type (2020-2025)
Figure 63. Europe Antimalarial Medication Sales Market Share by Application (2020-2025)
Figure 64. Germany Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 65. France Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Antimalarial Medication Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Antimalarial Medication Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Antimalarial Medication Sales Market Share by Application (2020-2025)
Figure 72. Egypt Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Antimalarial Medication in 2025
Figure 78. Manufacturing Process Analysis of Antimalarial Medication
Figure 79. Industry Chain Structure of Antimalarial Medication
Figure 80. Channels of Distribution
Figure 81. Global Antimalarial Medication Sales Market Forecast by Region (2026-2031)
Figure 82. Global Antimalarial Medication Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Antimalarial Medication Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Antimalarial Medication Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Antimalarial Medication Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Antimalarial Medication Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Antimalarial Medication
Figure 2. Antimalarial Medication Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antimalarial Medication Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Antimalarial Medication Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Antimalarial Medication Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Antimalarial Medication Sales Market Share by Country/Region (2024)
Figure 10. Antimalarial Medication Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Plasmodium Falciparum
Figure 12. Product Picture of Plasmodium Malariae
Figure 13. Product Picture of Plasmodium Vivax
Figure 14. Product Picture of Plasmodium Ovale
Figure 15. Global Antimalarial Medication Sales Market Share by Type in 2025
Figure 16. Global Antimalarial Medication Revenue Market Share by Type (2020-2025)
Figure 17. Antimalarial Medication Consumed in Hospital Pharmacy
Figure 18. Global Antimalarial Medication Market: Hospital Pharmacy (2020-2025) & (K Units)
Figure 19. Antimalarial Medication Consumed in Retail Pharmacy
Figure 20. Global Antimalarial Medication Market: Retail Pharmacy (2020-2025) & (K Units)
Figure 21. Antimalarial Medication Consumed in E- Commerce
Figure 22. Global Antimalarial Medication Market: E- Commerce (2020-2025) & (K Units)
Figure 23. Antimalarial Medication Consumed in Others
Figure 24. Global Antimalarial Medication Market: Others (2020-2025) & (K Units)
Figure 25. Global Antimalarial Medication Sale Market Share by Application (2024)
Figure 26. Global Antimalarial Medication Revenue Market Share by Application in 2025
Figure 27. Antimalarial Medication Sales by Company in 2025 (K Units)
Figure 28. Global Antimalarial Medication Sales Market Share by Company in 2025
Figure 29. Antimalarial Medication Revenue by Company in 2025 ($ millions)
Figure 30. Global Antimalarial Medication Revenue Market Share by Company in 2025
Figure 31. Global Antimalarial Medication Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Antimalarial Medication Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Antimalarial Medication Sales 2020-2025 (K Units)
Figure 34. Americas Antimalarial Medication Revenue 2020-2025 ($ millions)
Figure 35. APAC Antimalarial Medication Sales 2020-2025 (K Units)
Figure 36. APAC Antimalarial Medication Revenue 2020-2025 ($ millions)
Figure 37. Europe Antimalarial Medication Sales 2020-2025 (K Units)
Figure 38. Europe Antimalarial Medication Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Antimalarial Medication Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Antimalarial Medication Revenue 2020-2025 ($ millions)
Figure 41. Americas Antimalarial Medication Sales Market Share by Country in 2025
Figure 42. Americas Antimalarial Medication Revenue Market Share by Country (2020-2025)
Figure 43. Americas Antimalarial Medication Sales Market Share by Type (2020-2025)
Figure 44. Americas Antimalarial Medication Sales Market Share by Application (2020-2025)
Figure 45. United States Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Antimalarial Medication Sales Market Share by Region in 2025
Figure 50. APAC Antimalarial Medication Revenue Market Share by Region (2020-2025)
Figure 51. APAC Antimalarial Medication Sales Market Share by Type (2020-2025)
Figure 52. APAC Antimalarial Medication Sales Market Share by Application (2020-2025)
Figure 53. China Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 57. India Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Antimalarial Medication Sales Market Share by Country in 2025
Figure 61. Europe Antimalarial Medication Revenue Market Share by Country (2020-2025)
Figure 62. Europe Antimalarial Medication Sales Market Share by Type (2020-2025)
Figure 63. Europe Antimalarial Medication Sales Market Share by Application (2020-2025)
Figure 64. Germany Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 65. France Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Antimalarial Medication Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Antimalarial Medication Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Antimalarial Medication Sales Market Share by Application (2020-2025)
Figure 72. Egypt Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Antimalarial Medication Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Antimalarial Medication in 2025
Figure 78. Manufacturing Process Analysis of Antimalarial Medication
Figure 79. Industry Chain Structure of Antimalarial Medication
Figure 80. Channels of Distribution
Figure 81. Global Antimalarial Medication Sales Market Forecast by Region (2026-2031)
Figure 82. Global Antimalarial Medication Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Antimalarial Medication Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Antimalarial Medication Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Antimalarial Medication Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Antimalarial Medication Revenue Market Share Forecast by Application (2026-2031)
